Sekito Sho, Ogura Yuji, Soga Norihito, Kojima Takahiro
Department of Urology, Aichi Cancer Center Hospital, Nagoya, Japan.
Cancer Diagn Progn. 2022 May 3;2(3):345-350. doi: 10.21873/cdp.10115. eCollection 2022 May-Jun.
BACKGROUND/AIM: We investigated pre-operative factors for predicting whether renal masses are benign in order to facilitate the selection of optimal candidates for pre-operative biopsy.
We evaluated 278 patients with renal masses suspected to be clinically T1 or T2 renal cell carcinoma. All patients had undergone a partial or radical nephrectomy. Pre-operative parameters, including patient characteristics, tumor size, and blood tests, were utilized to predict which lesions were benign.
Twenty-five lesions (9.0%) were benign. Multivariate analysis showed that female sex [odds ratio (OR)=2.92, p=0.016], serum albumin ≥4.3 g/dl (OR=3.50, p=0.013), and tumor size <23 mm (OR=3.96, p=0.002) were significant independent factors for benign renal masses. The incidence of benign lesions in cases with all three factors (female sex, higher serum albumin, and smaller tumor size) was 4 of 16 (25.0%), which was significantly higher (p=0.037) than that in all cases (25/278; 9.0%).
Relatively high pre-operative serum albumin levels may be a predictor of benign lesions when associated with female sex and smaller tumor size.
背景/目的:我们研究了预测肾肿块是否为良性的术前因素,以利于选择术前活检的最佳候选者。
我们评估了278例疑似临床T1或T2期肾细胞癌的肾肿块患者。所有患者均接受了部分或根治性肾切除术。利用术前参数,包括患者特征、肿瘤大小和血液检查,来预测哪些病变是良性的。
25个病变(9.0%)为良性。多因素分析显示,女性[比值比(OR)=2.92,p=0.016]、血清白蛋白≥4.3 g/dl(OR=3.50,p=0.013)和肿瘤大小<23 mm(OR=3.96,p=0.002)是肾良性肿块的显著独立因素。具备所有三个因素(女性、较高血清白蛋白和较小肿瘤大小)的病例中良性病变的发生率为16例中的4例(25.0%),显著高于所有病例(25/278;9.0%)(p=0.037)。
术前血清白蛋白水平相对较高,若与女性性别和较小肿瘤大小相关,可能是良性病变的一个预测指标。